| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 96156 |
|
10,774 |
10,743 |
$860K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,495 |
12,281 |
$519K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,043 |
13,984 |
$358K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,051 |
3,973 |
$187K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,332 |
5,307 |
$172K |
| 92552 |
|
9,954 |
9,923 |
$146K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,391 |
3,376 |
$119K |
| G9920 |
Screening performed and negative |
12,819 |
12,730 |
$114K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,706 |
1,705 |
$72K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
7,254 |
7,139 |
$70K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
3,940 |
3,937 |
$59K |
| 99381 |
|
748 |
748 |
$55K |
| 99188 |
|
3,329 |
3,317 |
$50K |
| 99383 |
|
767 |
762 |
$46K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
2,124 |
2,116 |
$40K |
| 90697 |
|
1,741 |
1,728 |
$40K |
| 96127 |
|
6,869 |
6,725 |
$34K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
743 |
740 |
$33K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
461 |
460 |
$30K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,556 |
1,491 |
$30K |
| 90686 |
|
3,713 |
3,702 |
$28K |
| 99382 |
|
394 |
393 |
$25K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
953 |
944 |
$25K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
324 |
324 |
$24K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
158 |
157 |
$18K |
| 99000 |
|
5,276 |
5,180 |
$17K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,650 |
1,579 |
$16K |
| 90671 |
|
1,798 |
1,788 |
$16K |
| 83655 |
|
1,537 |
1,536 |
$13K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
122 |
121 |
$12K |
| 99205 |
Prolong outpt/office vis |
141 |
140 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
405 |
397 |
$12K |
| 90633 |
|
1,474 |
1,469 |
$11K |
| 90670 |
|
1,696 |
1,669 |
$11K |
| 90651 |
|
1,235 |
1,229 |
$9K |
| 90680 |
|
1,262 |
1,251 |
$9K |
| 99384 |
|
135 |
135 |
$9K |
| G9919 |
Screening performed and positive and provision of recommendations |
3,466 |
3,439 |
$7K |
| 85018 |
|
3,745 |
3,733 |
$7K |
| 90698 |
|
1,182 |
1,158 |
$6K |
| 0071A |
|
142 |
142 |
$6K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
1,201 |
1,103 |
$5K |
| 0072A |
|
123 |
123 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
45 |
45 |
$5K |
| 90656 |
|
558 |
555 |
$4K |
| 90716 |
|
546 |
545 |
$4K |
| 90707 |
|
543 |
542 |
$4K |
| 99385 |
|
31 |
31 |
$4K |
| 90710 |
|
471 |
468 |
$4K |
| 90619 |
|
422 |
422 |
$4K |
| 90696 |
|
451 |
448 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
197 |
188 |
$2K |
| 0002A |
|
53 |
53 |
$2K |
| 0001A |
|
43 |
43 |
$2K |
| 90744 |
|
407 |
394 |
$2K |
| 90681 |
|
192 |
191 |
$2K |
| 98960 |
|
69 |
69 |
$1K |
| 99173 |
|
361 |
360 |
$1K |
| 90715 |
|
172 |
170 |
$1K |
| 90480 |
|
30 |
30 |
$1K |
| 90620 |
|
168 |
168 |
$1K |
| 94760 |
|
203 |
193 |
$1K |
| 81002 |
|
471 |
465 |
$798.75 |
| 92551 |
|
87 |
87 |
$738.34 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
83 |
82 |
$512.08 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
268 |
262 |
$465.82 |
| 90734 |
|
116 |
112 |
$404.73 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15 |
15 |
$278.40 |
| 91319 |
|
13 |
13 |
$263.34 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
25 |
25 |
$202.80 |
| 90700 |
|
12 |
12 |
$98.01 |
| 86580 |
|
27 |
27 |
$80.25 |
| 87081 |
|
14 |
13 |
$73.06 |
| 96160 |
|
868 |
848 |
$66.02 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$57.46 |
| 4004F |
|
5,215 |
5,193 |
$33.75 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
180 |
172 |
$28.78 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
214 |
209 |
$18.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
72 |
72 |
$17.52 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
12 |
12 |
$1.89 |
| 3074F |
|
1,304 |
1,216 |
$0.00 |
| 96161 |
|
3,585 |
3,510 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
91 |
91 |
$0.00 |
| 3079F |
|
509 |
483 |
$0.00 |
| 3080F |
|
42 |
38 |
$0.00 |
| 3075F |
|
156 |
151 |
$0.00 |
| 3044F |
|
104 |
104 |
$0.00 |
| 3078F |
|
1,021 |
957 |
$0.00 |
| 3077F |
|
104 |
94 |
$0.00 |
| 90461 |
|
37 |
37 |
$0.00 |